{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:14:46Z","timestamp":1791188086278,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Immun"],"published-print":{"date-parts":[[2002,6,1]]},"DOI":"10.1038\/sj.gene.6363851","type":"journal-article","created":{"date-parts":[[2002,9,3]],"date-time":"2002-09-03T19:13:03Z","timestamp":1031080383000},"page":"229-232","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":130,"title":["Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoma"],"prefix":"10.1038","volume":"3","author":[{"given":"W M","family":"Howell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A C","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S J","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J M","family":"Theaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,6,12]]},"reference":[{"key":"BF6363851_CR1","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1126\/science.2479986","volume":"246","author":"DW Leung","year":"1989","unstructured":"Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N . Vascular endothelial growth factor is a secreted angiogenic mitogen Science 1989 246: 1306\u20131309","journal-title":"Science"},{"key":"BF6363851_CR2","doi-asserted-by":"crossref","first-page":"11947","DOI":"10.1016\/S0021-9258(18)99049-6","volume":"266","author":"E Tischer","year":"1991","unstructured":"Tischer E, Mitchell R, Hartman T et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing J Biol Chem 1991 266: 11947\u201311954","journal-title":"J Biol Chem"},{"key":"BF6363851_CR3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/BF00437469","volume":"15","author":"KP Claffey","year":"1996","unstructured":"Claffey KP, Robinson GS . Regulation of VEGF\/VPF expression in tumour cells: consequences for tumour growth and metastasis Cancer Metastasis Rev 1996 15: 165\u2013176","journal-title":"Cancer Metastasis Rev"},{"key":"BF6363851_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1091\/mbc.3.2.211","volume":"3","author":"B Berse","year":"1992","unstructured":"Berse B, Brown LF, Van de Water L, Dvorak HF, Senger DR . Vascular permeability factor (vascular endothelial growth factor) gene is expressed differently in normal tissues, macrophages and tumors Mol Biol Cell 1992 3: 211\u2013220","journal-title":"Mol Biol Cell"},{"key":"BF6363851_CR5","first-page":"4140","volume":"55","author":"MR Freeman","year":"1995","unstructured":"Freeman MR, Schneck FX, Gagnon ML . Peripheral blood lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis Cancer Res 1995 55: 4140\u20134145","journal-title":"Cancer Res"},{"key":"BF6363851_CR6","first-page":"770","volume":"12","author":"IB Bayer-Garner","year":"1999","unstructured":"Bayer-Garner IB, Hough AJ, Smoller MD . Vascular endothelial growth factor expression in malignant melanoma: prognostic versus diagnostic usefulness Mod Pathol 1999 12: 770\u2013774","journal-title":"Mod Pathol"},{"key":"BF6363851_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/00008390-199902000-00008","volume":"9","author":"T Vlaykova","year":"1999","unstructured":"Vlaykova T, Laurila P, Muhonen T et al. Prognostic value of tumour vascularity in metastatic melanoma and association of blood vessel density with vascular endothelial growth factor expression Melanoma Res 1999 9: 59\u201368","journal-title":"Melanoma Res"},{"key":"BF6363851_CR8","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1054\/bjoc.2000.1173","volume":"82","author":"T Danielsen","year":"2000","unstructured":"Danielsen T, Rofstad EK . The constitutive level of vascular endothelial growth factor (VEGF) is more important than hypoxia-induced VEGF up-regulation in the angiogenesis of human melanoma xenografts Br J Cancer 2000 82: 1528\u20131534","journal-title":"Br J Cancer"},{"key":"BF6363851_CR9","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0198-8859(99)00132-9","volume":"60","author":"IJ Brogan","year":"1999","unstructured":"Brogan IJ, Khan N, Isaac K, Hutchinson JA, Pravica V, Hutchinson IV . Novel polymorphisms in the promoter and 5\u2032 UTR regions of the human vascular endothelial growth factor gene Hum Immunol 1999 60: 1245\u20131249","journal-title":"Hum Immunol"},{"key":"BF6363851_CR10","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1006\/cyto.2000.0692","volume":"12","author":"CJ Watson","year":"2000","unstructured":"Watson CJ, Webb NJA, Bottomley MJ, Brenchley PEC . Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production Cytokine 2000 12: 1232\u20131235","journal-title":"Cytokine"},{"key":"BF6363851_CR11","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1159\/000054076","volume":"37","author":"W Renner","year":"2000","unstructured":"Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E . A common 936 C\/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels J Vasc Res 2000 37: 443\u2013448","journal-title":"J Vasc Res"},{"key":"BF6363851_CR12","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1681\/ASN.V131260","volume":"13","author":"M Shahbazi","year":"2002","unstructured":"Shahbazi M, Fryer AA, Pravica V, Brogan IJ, Ramsay HM, Hutchinson IV . Polymorphisms in vascular endothelial growth factor gene are associated with increased risk of acute rejection in renal transplant recipients J Am Soc Nephrol 2002 13: 260\u2013264","journal-title":"J Am Soc Nephrol"},{"key":"BF6363851_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/sj.gene.6363726","volume":"2","author":"WM Howell","year":"2001","unstructured":"Howell WM, Turner SJ, Bateman AC, Theaker JM . IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma Genes Immun 2001 2: 25\u201331","journal-title":"Genes Immun"},{"key":"BF6363851_CR14","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/jnci\/81.24.1893","volume":"81","author":"WH Clark Jr","year":"1989","unstructured":"Clark WH Jr, Elder DE, Guerry D IV et al. Model predicting survival in stage I melanoma based on tumour progression J Natl Cancer Inst 1989 81: 1893\u20131904","journal-title":"J Natl Cancer Inst"},{"key":"BF6363851_CR15","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/S0140-6736(85)90126-6","volume":"2","author":"RM Mackie","year":"1985","unstructured":"Mackie RM, Smyth JF, Soutar DS et al. Malignant melanoma in Scotland 1979\u20131983 Lancet 1985 2: 859","journal-title":"Lancet"},{"key":"BF6363851_CR16","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0140-6736(92)91539-K","volume":"339","author":"R Mackie","year":"1992","unstructured":"Mackie R, Hunter JA, Aitchison TC et al. Cutaneous malignant melanoma, Scotland, 1979\u20131983. The Scottish Melanoma Group Lancet 1992 339: 971\u2013975","journal-title":"Lancet"},{"key":"BF6363851_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1309\/WAVR-560R-NU5E-4Q96","volume":"115","author":"RT Vollmer","year":"2001","unstructured":"Vollmer RT, Seigler HF . Using a continuous transformation of the Breslow thickness for prognosis in cutaneous melanoma Am J Clin Pathol 2001 115: 205\u2013212","journal-title":"Am J Clin Pathol"},{"key":"BF6363851_CR18","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1073\/pnas.95.4.1741","volume":"95","author":"A Collins","year":"1998","unstructured":"Collins A, Morton NE . Mapping a disease locus by allelic association Proc Natl Acad Sci USA 1998 95: 1741\u20131745","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6363851_CR19","volume-title":"Handbook of Human Genetic Linkage","author":"JD Terwilliger","year":"1994","unstructured":"Terwilliger JD, Ott J . Handbook of Human Genetic Linkage The Johns Hopkins University Press; Baltimore 1994"},{"key":"BF6363851_CR20","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/(SICI)1097-0215(19970516)71:4<630::AID-IJC20>3.0.CO;2-E","volume":"71","author":"FY Yue","year":"1997","unstructured":"Yue FY, Dummer R, Geertsen R et al. Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules Int J Cancer 1997 71: 630\u2013637","journal-title":"Int J Cancer"},{"key":"BF6363851_CR21","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1084\/jem.184.2.579","volume":"184","author":"LM Zheng","year":"1996","unstructured":"Zheng LM, Ojcius DM, Garaud F et al. Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism J Exp Med 1996 184: 579\u2013584","journal-title":"J Exp Med"},{"key":"BF6363851_CR22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1399-0039.1992.tb01940.x","volume":"39","author":"O Olerup","year":"1992","unstructured":"Olerup O, Zetterquist H . HLA-DR typing by PCR amplification and sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation Tissue Antigens 1992 39: 225\u2013235","journal-title":"Tissue Antigens"}],"container-title":["Genes &amp; Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/6363851.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/6363851","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/6363851.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T18:47:25Z","timestamp":1647974845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6363851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6,1]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,6,1]]}},"alternative-id":["BF6363851"],"URL":"https:\/\/doi.org\/10.1038\/sj.gene.6363851","relation":{},"ISSN":["1466-4879","1476-5470"],"issn-type":[{"value":"1466-4879","type":"print"},{"value":"1476-5470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,6,1]]},"assertion":[{"value":"23 August 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2001","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2002","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2002","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}